Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States. Mauskopf J, Fay M, Iyer R, Sarda S, Livingston T J Med Econ. 2015 Dec 26:1-36. PMID: 26707273. Abstract CommentRecommendBookmarkWatch